Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH

Human Reproduction

Volumn 16, Issue 9, 2001, Pages 1875-1879

  De Placido, Giuseppe ^a   Mollo, Antonio ^a   Alviggi, Carlo ^a   Strina, Ida ^a   Varricchio, Maria Teresa ^a   Ranieri, Antonio ^a   Colacurci, Nicola ^a   Tolino, Achille ^a   Wilding, Martin ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Clinica Villa del Sole   (Italy)

Author keywords

Gonadotrophin; Human oocyte; Luteinizing hormone; Pituitary; Poor responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYPOPHYSIS; LONG TERM CARE; OOCYTE; OVULATION INDUCTION; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034803884     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.9.1875     Document Type: Article

References (36)

1. Recombinant follicle stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome
2. Ovarian response to recombinant human follicle-stimulating hormone in luteinizing hormone-depleted women: Examination of the two cell/two gonadotrophin theory
3. Revaluation of the roles of luteinizing hormone and follicle stimulating hormone in the ovulatory process
4. Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotrophin deficiency
5. Stimulation of aromatase activity by follicle stimulating hormone in rat granulosa cells in vivo and in vitro
6. Minidose gonadotrophin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels
7. Synergism of follicle stimulating and luteinizing hormones in producing estrogen secretion
8. Clinical review 81: Gonadotrophin-releasing hormone analogues in ovulation induction: Current status and perspectives
9. The role of luteinizing hormone in folliculogenesis and ovulation induction
10. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone
11. Suppression of LH during ovarian stimulation: Effects differ in cycles stimulated with purified urinary FSH and recombinant FSH
12. Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in vitro fertilisation: A prospective, randomised, assessor-blind, multicentre trial
13. The routine use of gonadotrophin-releasing hormone agonists prior to in-vitro fertilisation and gamete intrafallopian transfer: A meta-analysis of randomised controlled trials
14. Mutations and polymorphisms in gonadotropin genes
15. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: Additional mutations and differential function of the promoter sequence
16. Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotrophic women
17. The role of LH in ovarian stimulation: Exogenous LH, let's design the future
18. Effects of recombinant human FSH (rhFSH), urinary purified FSH (uFSH), and hMG on small preantral follicles and tertiary follicles from normal adult and androgen-sterilized female mice
19. Assessment of the role of serum luteinising hormone and estradiol response to follicle-stimulating hormone on in-vitro fertilisation treatment outcome
20. Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients
21. Low day 3 luteinizing hormone levels are predictive of reduced response to ovarian stimulation
22. A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3
23. Recombinant follicle stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in-vitro fertilisation than urinary gonadotrophins
24. The significance of delayed suppression using buserelin acetate and recombinant follicle-stimulating hormone in a long protocol in vitro fertilisation program
25. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome
26. Human recombinant follicle stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and oestrogen biosynthesis in women with isolated gonadotrophin deficiency
27. Bioactivity of luteinizing hormone during normal puberty in girls and boys
28. Steroids in the follicular fluid and the corpus luteum of the mare. A 'two-cell type' theory of ovarian steroid synthesis
29. A prospective randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilisation
30. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive technologies
31. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilisation
32. Short protocol of gonadotropin releasing hormone agonist administration gave better results in long protocol poor-responder in IVF-ET
33. Recombinant human luteinising hormone (LH) to support recombinant human follicle stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: A dose-finding study
34. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist Ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®)
35. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction
36. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserilin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilisation and embryo transfer programme